Ischemic Stroke Clinical Trials in Charlottesville, Virginia

5 studies are recruiting for ischemic stroke in Charlottesville, Virginia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

    The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Virginia, Charlottesville, Virginia
    Locations
    31 in total
    Run by
    Massachusetts General Hospital

    See if you can join NCT04916210 on ClinicalTrials.gov

  2. Strategy for Improving Stroke Treatment Response

    SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UVA Medical Center, Charlottesville, Virginia
    Locations
    52 in total
    Run by
    Translational Sciences, Inc.

    See if you can join NCT05948566 on ClinicalTrials.gov

  3. CTSN Embolic Protection Trial

    This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

    Stage
    Not phased
    Ages
    60 and older
    Site
    University of Virginia, Charlottesville, Virginia
    Locations
    28 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT06027788 on ClinicalTrials.gov

  4. Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

    The goal of this observational study is to use a genetic test to help doctors prescribe the most effective medications after a patient has a stroke. One type of stroke is caused by a blood clot in brain vessels. After a patient has this kind of stroke, they are often given a combination of two bloo…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Virginia, Charlottesville, Virginia
    Run by
    University of Virginia

    See if you can join NCT06292117 on ClinicalTrials.gov

  5. StrokeNet Thrombectomy Endovascular Platform

    STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

    Stage
    Not phased
    Ages
    18 and older
    Site
    UVA Medical Center, Charlottesville, Virginia
    Locations
    41 in total
    Run by
    Medical University of South Carolina

    See if you can join NCT06289985 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.